MedTrace Logo

Antibiotic Treatment of Multiple Erythema Migrans

NCT01163994 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2017-05-05

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and safety of 15-day ceftriaxone versus 15-day doxycycline treatment in patients with multiple erythema migrans.

Conditions

  • Multiple Erythema Migrans

Interventions

DRUG

ceftriaxone

intravenously, 2 g, qd, 15 days

DRUG

doxycycline

orally, 100 mg, bid, 15 days

OTHER

erythema migrans patients treated with doxycycline

orally, 100 mg, bid, 15 days

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Principal Investigators

  • Franc Strle, MD · UMC Ljubljana

  • Dasa Stupica, MD · UMC Ljubljana, Department of Infectious Diseases Ljubljana, Slovenia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01163994 on ClinicalTrials.gov